Drugs used for crhd
Reading File
Finding Sources
Finding Sources
Searching PubMed
"rheumatic heart disease" AND management
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I now have comprehensive data from the textbooks. Let me compile a thorough answer on drugs used in CRHD (Chronic Rheumatic Heart Disease).
Drugs Used in Chronic Rheumatic Heart Disease (CRHD)
CRHD is the end result of repeated attacks of acute rheumatic fever (ARF) leading to permanent valvular damage - most commonly mitral stenosis, mitral regurgitation, and aortic valve disease. Drug therapy addresses three main goals: (1) preventing recurrences of ARF, (2) managing valvular complications, and (3) treating heart failure and arrhythmias.
1. Secondary Prophylaxis (Most Important Category)
The cornerstone of CRHD management is lifelong antibiotic prophylaxis to prevent recurrent streptococcal infections and further valve damage.
Drug of Choice
Benzathine Penicillin G (IM)
- Dose: 1.2 million units IM every 4 weeks (patients >27 kg); 600,000 units IM every 4 weeks (patients ≤27 kg)
- Injections every 3 or 2 weeks are more effective in high-risk patients
- Preferred route because compliance is assured
- Fuster and Hurst's The Heart, 15th Ed and Braunwald's Heart Disease both confirm this as the standard recommendation
Oral Alternative
Penicillin V (phenoxymethyl penicillin)
- Dose: 250 mg orally twice daily
- Preferred in thin patients on warfarin anticoagulation (where deep IM injections are undesirable)
- Less reliable due to compliance issues
If Penicillin-Allergic
| Drug | Dose | Duration |
|---|---|---|
| Sulfadiazine | 0.5 g/day (<30 kg); 1 g/day (>30 kg) orally | Long-term |
| Erythromycin / Macrolides (azithromycin) | 250 mg twice daily | Long-term |
| Narrow-spectrum cephalosporins (cephalexin) | Variable | Long-term |
Duration of Secondary Prophylaxis
| Clinical Scenario | Duration |
|---|---|
| ARF without carditis | 5 years or until age 21, whichever is longer |
| ARF with carditis, no residual valve disease | 10 years or until age 21, whichever is longer |
| ARF with carditis + persistent valvular disease | Until age 35-40 years or lifelong |
| After valve replacement surgery | Lifelong |
2. Primary Prevention (for ARF that leads to CRHD)
To prevent the initial ARF attack by eradicating GAS pharyngitis:
| Drug | Dose | Route | Duration |
|---|---|---|---|
| Benzathine Penicillin G | 1.2 million U (>27 kg); 600,000 U (≤27 kg) | IM | Single dose |
| Penicillin V | Children: 250 mg 2-3x/day; Adults: 500 mg 2-3x/day | Oral | 10 days |
| Amoxicillin | 50 mg/kg once daily (max 1 g) | Oral | 10 days |
| Cephalexin / Cefadroxil | Variable | Oral | 10 days |
| Clindamycin | 20 mg/kg/day in 3 doses (max 1.8 g/day) | Oral | 10 days |
| Azithromycin | 12 mg/kg once daily (max 500 mg) | Oral | 5 days |
| Clarithromycin | 15 mg/kg/day in 2 divided doses | Oral | 10 days |
- Antibiotic treatment reduces ARF attack rate by 70-80%
- Braunwald's Heart Disease (Table 81.4, p. 861)
3. Anti-inflammatory Therapy (for Active Carditis / ARF flares)
Without Carditis or Mild Carditis
- Aspirin (Acetylsalicylic acid): High-dose 50-70 mg/kg/day (max 4-6 g/day) - drug of choice for arthritis and mild carditis
- Naproxen: Used as alternative NSAID
With Moderate-Severe Carditis / Heart Failure
- Corticosteroids (Prednisone): 1-2 mg/kg/day (max 80 mg/day) - used when severe carditis is present; tapered over 2-3 weeks
- Overlap with aspirin during steroid taper to prevent rebound
Note: Anti-inflammatory therapy does NOT prevent progression to chronic valve disease.
4. Treatment of Valvular Complications
Heart Failure from Valvular Disease
- Diuretics (furosemide, hydrochlorothiazide) - reduce preload, pulmonary congestion
- Digoxin - for rate control in atrial fibrillation + systolic dysfunction
- ACE inhibitors / ARBs - for mitral or aortic regurgitation with LV dysfunction
- Beta-blockers (metoprolol, bisoprolol) - rate control in atrial fibrillation, HF management
Atrial Fibrillation (common complication of mitral stenosis)
- Beta-blockers or diltiazem - rate control
- Digoxin - rate control (especially when activity is limited)
- Electrical cardioversion - rhythm control in selected patients
Anticoagulation
- Warfarin (target INR 2-3, or 2.5-3.5 with mechanical valve): Mandatory in:
- Mitral stenosis + atrial fibrillation
- Any mechanical prosthetic valve
- Mitral stenosis + prior embolic event
- Mitral stenosis + left atrial thrombus
- Novel oral anticoagulants (NOACs) - generally not recommended for patients with mechanical valves or significant mitral stenosis (rheumatic etiology)
Infective Endocarditis Prophylaxis
- Amoxicillin 2 g orally 1 hour before dental procedures (or ampicillin IM/IV)
- Clindamycin if penicillin-allergic (600 mg orally)
- Indicated for all patients with prosthetic valves and history of prior endocarditis
5. Sydenham's Chorea (neurological manifestation)
- Haloperidol or valproate - first-line symptomatic treatment
- Carbamazepine - alternative
- Corticosteroids / IVIG / plasmapheresis - for severe, refractory cases (limited evidence)
Summary Table
| Category | Drug(s) | Purpose |
|---|---|---|
| Secondary prophylaxis | Benzathine Penicillin G IM | Prevent ARF recurrence (most important) |
| Penicillin allergy | Sulfadiazine, Erythromycin, Azithromycin | Secondary prophylaxis alternative |
| Anti-inflammatory | Aspirin, Naproxen | ARF arthritis/mild carditis |
| Severe carditis | Prednisone | Suppress inflammation |
| Heart failure | Furosemide, Digoxin, ACE inhibitors, Beta-blockers | Manage valvular HF |
| Anticoagulation | Warfarin | AF + MS, mechanical valves |
| AF rate control | Digoxin, Beta-blockers, Diltiazem | Control ventricular rate |
| IE prophylaxis | Amoxicillin, Clindamycin | Before invasive procedures |
| Chorea | Haloperidol, Valproate | Symptomatic relief |
Key point: Secondary prophylaxis with benzathine penicillin G is the most important drug intervention in CRHD. A 2024 Cochrane systematic review (PMID 39312290) confirmed that long-term antibiotic prophylaxis significantly prevents rheumatic fever recurrence and progression of valve disease. Definitive treatment for severe valvular disease remains surgical (commissurotomy, valve repair, or replacement).
Sources: Fuster and Hurst's The Heart, 15th Ed; Braunwald's Heart Disease; Firestein & Kelley's Textbook of Rheumatology; Goldman-Cecil Medicine
This is a shared conversation. Sign in to Orris to start your own chat.